Medicines and Medical Devices Safety Review

Department of Health and Social Care written question – answered on 16th July 2018.

Alert me about debates like this

Photo of Owen Smith Owen Smith Labour, Pontypridd

To ask the Secretary of State for Health and Social Care, pursuant to the Written Statement of 10 July 2018 on Update on the Independent Medicines and Medical Devices Safety Review, HCWS841, if he will publish in detail the Government’s plan for a high vigilance programme of restricted practice for the use of surgical mesh to treat stress urinary incontinence.

Photo of Jackie Doyle-Price Jackie Doyle-Price The Parliamentary Under-Secretary for Health and Social Care

On 10 July, alongside the Government’s announcement of a pause in the use of sling/tape to treat stress urinary incontinence and vaginally inserted mesh to treat prolapse, NHS England and NHS Improvement wrote to provider Chief Executives and Medical Directors, advising on implementation of the pause through a high vigilance programme of restriction. It was advised that, for the majority of patients, a delay until the high vigilance programme ceased would be the preferred option. This information is in the public domain and available on the NHS Improvement website at the following link:

https://i.emlfiles4.com/cmpdoc/9/7/2/8/1/1/files/47633_mesh-letter-to-acute-ceos-and-mds.pdf

A Clinical Advisory Group has been formed, with subject matter expert members representing NHS England, British Society of Urogynaecology and British Association of Urological Surgeons. The Clinical Advisory Group is developing clinical recommendations for implementation following the initial advice given to providers. NHS England will ensure that these clinical recommendations are communicated to providers once they are agreed.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.